vs
Steris(STE)与TKO Group Holdings(TKO)财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是TKO Group Holdings的1.4倍($1.5B vs $1.0B),Steris净利率更高(12.9% vs -0.2%,领先13.1%),TKO Group Holdings同比增速更快(61.6% vs 9.2%),过去两年TKO Group Holdings的营收复合增速更高(28.4% vs 15.8%)
Steris plc是一家美爱合资的医疗设备企业,专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市,深耕医疗消毒、感染防控、手术耗材等领域,为医疗机构提供专业可靠的医疗解决方案。
TKO Group Holdings是美国体育及体育娱乐上市企业,成立于2023年9月12日,由奋进集团(Endeavor)子公司、终极格斗冠军赛(UFC)母公司Zuffa与职业摔跤品牌世界摔角娱乐(WWE)合并组建,主营综合格斗、职业摔跤赛事运营及相关娱乐内容业务。
STE vs TKO — 直观对比
营收规模更大
STE
是对方的1.4倍
$1.0B
营收增速更快
TKO
高出52.5%
9.2%
净利率更高
STE
高出13.1%
-0.2%
两年增速更快
TKO
近两年复合增速
15.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.5B | $1.0B |
| 净利润 | $192.9M | $-2.4M |
| 毛利率 | 43.8% | — |
| 营业利润率 | 18.3% | 5.5% |
| 净利率 | 12.9% | -0.2% |
| 营收同比 | 9.2% | 61.6% |
| 净利润同比 | 11.2% | -107.7% |
| 每股收益(稀释后) | $1.96 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
STE
TKO
| Q4 25 | $1.5B | $1.0B | ||
| Q3 25 | $1.5B | $1.1B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.4B | $642.2M | ||
| Q3 24 | $1.3B | $681.3M | ||
| Q2 24 | $1.3B | $851.2M | ||
| Q1 24 | $1.1B | $629.7M |
净利润
STE
TKO
| Q4 25 | $192.9M | $-2.4M | ||
| Q3 25 | $191.9M | $41.0M | ||
| Q2 25 | $177.4M | $98.4M | ||
| Q1 25 | $145.7M | $58.4M | ||
| Q4 24 | $173.5M | $31.0M | ||
| Q3 24 | $150.0M | $23.1M | ||
| Q2 24 | $145.4M | $59.1M | ||
| Q1 24 | $-1.4M | $-103.8M |
毛利率
STE
TKO
| Q4 25 | 43.8% | — | ||
| Q3 25 | 44.2% | — | ||
| Q2 25 | 45.1% | — | ||
| Q1 25 | 43.3% | — | ||
| Q4 24 | 44.5% | — | ||
| Q3 24 | 43.6% | — | ||
| Q2 24 | 44.7% | — | ||
| Q1 24 | 40.2% | — |
营业利润率
STE
TKO
| Q4 25 | 18.3% | 5.5% | ||
| Q3 25 | 18.2% | 15.4% | ||
| Q2 25 | 17.7% | 28.1% | ||
| Q1 25 | 14.6% | 18.7% | ||
| Q4 24 | 17.9% | 15.9% | ||
| Q3 24 | 16.5% | 20.0% | ||
| Q2 24 | 14.5% | 30.0% | ||
| Q1 24 | 22.0% | -33.4% |
净利率
STE
TKO
| Q4 25 | 12.9% | -0.2% | ||
| Q3 25 | 13.1% | 3.7% | ||
| Q2 25 | 12.8% | 7.5% | ||
| Q1 25 | 9.8% | 4.6% | ||
| Q4 24 | 12.7% | 4.8% | ||
| Q3 24 | 11.3% | 3.4% | ||
| Q2 24 | 11.4% | 6.9% | ||
| Q1 24 | -0.1% | -16.5% |
每股收益(稀释后)
STE
TKO
| Q4 25 | $1.96 | $-0.07 | ||
| Q3 25 | $1.94 | $0.47 | ||
| Q2 25 | $1.79 | $1.17 | ||
| Q1 25 | $1.48 | $0.69 | ||
| Q4 24 | $1.75 | $0.28 | ||
| Q3 24 | $1.51 | $0.28 | ||
| Q2 24 | $1.46 | $0.72 | ||
| Q1 24 | $-0.02 | $-1.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $423.7M | $831.1M |
| 总债务越低越好 | $1.9B | $3.8B |
| 股东权益账面价值 | $7.2B | $3.7B |
| 总资产 | $10.6B | $15.5B |
| 负债/权益比越低杠杆越低 | 0.27× | 1.01× |
8季度趋势,按日历期对齐
现金及短期投资
STE
TKO
| Q4 25 | $423.7M | $831.1M | ||
| Q3 25 | $319.2M | $861.4M | ||
| Q2 25 | $279.7M | $535.1M | ||
| Q1 25 | $171.7M | $470.9M | ||
| Q4 24 | $155.2M | $525.6M | ||
| Q3 24 | $172.2M | $457.4M | ||
| Q2 24 | $198.3M | $277.5M | ||
| Q1 24 | $207.0M | $245.8M |
总债务
STE
TKO
| Q4 25 | $1.9B | $3.8B | ||
| Q3 25 | $1.9B | $3.7B | ||
| Q2 25 | $1.9B | $2.7B | ||
| Q1 25 | $1.9B | $2.8B | ||
| Q4 24 | $2.0B | $2.8B | ||
| Q3 24 | $2.2B | $2.7B | ||
| Q2 24 | $2.2B | $2.7B | ||
| Q1 24 | $3.1B | $2.7B |
股东权益
STE
TKO
| Q4 25 | $7.2B | $3.7B | ||
| Q3 25 | $7.0B | $3.8B | ||
| Q2 25 | $7.0B | $4.3B | ||
| Q1 25 | $6.6B | $4.2B | ||
| Q4 24 | $6.4B | $4.1B | ||
| Q3 24 | $6.6B | $4.0B | ||
| Q2 24 | $6.4B | $4.0B | ||
| Q1 24 | $6.3B | $4.0B |
总资产
STE
TKO
| Q4 25 | $10.6B | $15.5B | ||
| Q3 25 | $10.4B | $15.5B | ||
| Q2 25 | $10.4B | $15.3B | ||
| Q1 25 | $10.1B | $15.0B | ||
| Q4 24 | $10.0B | $12.7B | ||
| Q3 24 | $10.2B | $12.8B | ||
| Q2 24 | $10.1B | $12.7B | ||
| Q1 24 | $11.1B | $12.7B |
负债/权益比
STE
TKO
| Q4 25 | 0.27× | 1.01× | ||
| Q3 25 | 0.27× | 0.98× | ||
| Q2 25 | 0.27× | 0.64× | ||
| Q1 25 | 0.29× | 0.66× | ||
| Q4 24 | 0.32× | 0.67× | ||
| Q3 24 | 0.33× | 0.67× | ||
| Q2 24 | 0.35× | 0.68× | ||
| Q1 24 | 0.50× | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $298.2M | $309.9M |
| 自由现金流经营现金流 - 资本支出 | $199.5M | — |
| 自由现金流率自由现金流/营收 | 13.3% | — |
| 资本支出强度资本支出/营收 | 6.6% | — |
| 现金转化率经营现金流/净利润 | 1.55× | — |
| 过去12个月自由现金流最近4个季度 | $917.1M | — |
8季度趋势,按日历期对齐
经营现金流
STE
TKO
| Q4 25 | $298.2M | $309.9M | ||
| Q3 25 | $287.8M | $416.8M | ||
| Q2 25 | $420.0M | $396.2M | ||
| Q1 25 | $260.8M | $162.8M | ||
| Q4 24 | $332.8M | $56.8M | ||
| Q3 24 | $250.7M | $236.5M | ||
| Q2 24 | $303.7M | $230.7M | ||
| Q1 24 | $254.8M | $59.3M |
自由现金流
STE
TKO
| Q4 25 | $199.5M | — | ||
| Q3 25 | $201.3M | — | ||
| Q2 25 | $326.4M | — | ||
| Q1 25 | $189.9M | — | ||
| Q4 24 | $243.6M | — | ||
| Q3 24 | $148.8M | — | ||
| Q2 24 | $195.7M | — | ||
| Q1 24 | $163.3M | — |
自由现金流率
STE
TKO
| Q4 25 | 13.3% | — | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 23.5% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 15.3% | — | ||
| Q1 24 | 14.6% | — |
资本支出强度
STE
TKO
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 8.4% | — | ||
| Q1 24 | 8.2% | — |
现金转化率
STE
TKO
| Q4 25 | 1.55× | — | ||
| Q3 25 | 1.50× | 10.16× | ||
| Q2 25 | 2.37× | 4.03× | ||
| Q1 25 | 1.79× | 2.79× | ||
| Q4 24 | 1.92× | 1.83× | ||
| Q3 24 | 1.67× | 10.22× | ||
| Q2 24 | 2.09× | 3.90× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
TKO
| World Wrestling Entertainment Segment | $359.6M | 35% |
| IMG Segment | $247.6M | 24% |
| Media Rights Production And Content | $222.6M | 21% |
| Partnerships And Marketing | $93.3M | 9% |
| Live Events And Hospitality | $72.2M | 7% |
| Other | $29.4M | 3% |
| Consumer Products Licensing And Other | $13.2M | 1% |